Prostate specific antigen testing: summary guidance for GPs
- Public Health England
- Part of:
- Prostate cancer risk management programme: supporting documents
- First published:
- 1 January 2009
- Last updated:
- 29 March 2016, see all updates
This prostate cancer risk management programme (PCRMP) summary sheet helps GPs advise men who ask about prostate specific antigen (PSA) testing.
PDF, 82.7KB, 2 pages
This file may not be suitable for users of assistive technology. Request an accessible format.
If you use assistive technology (such as a screen reader) and need a version of this document in a more accessible format, please email email@example.com. Please tell us what format you need. It will help us if you say what assistive technology you use.
This summary sheet helps GPs give clear and balanced information to asymptomatic men who ask about prostate specific antigen (PSA) testing.
The PSA test is available free to any well man aged 50 and over who requests it.
GPs should not proactively raise the issue of PSA testing with asymptomatic men.
GPs should use their clinical judgement to manage symptomatic men and those aged under 50 who are considered to have higher risk for prostate cancer.
Published: 1 January 2009
Updated: 29 March 2016
- This summary information sheet for GPs is updated as part of the revised prostate cancer risk management programme materials published in March 2016
- First published.